07/02/2006

Womb cancer increase causes concern

Survival rates for womb cancer are increasing, according to a report, but there are concerns that the disease is increasing among the over-60s.

Cancer Research UK reported that five-year survival rates for womb cancer have risen to 77% - an improvement of 16% in the past 30 years.

However, the report found that the incidence of the disease in women aged between 60 to 79 has risen by 30% in less than a decade.

The charity said that greater awareness of the disease, its symptoms and risk factors was needed.

Cancer of the womb - which is also known as uterine cancer - affects around 6,000 women in the UK each year. This nearly twice as many people as cervical cancer and accounts for 4% of all female cancers.

Cancer Research UK said that early detection is crucial, as five-year survival rates for women with the advanced stage of the disease are as low as 25%.

Over 90% of womb cancers occur in women over the age of 50, while 75% occur in women who have been through the menopause.

Awareness of the disease is low, so many women may be unaware that vaginal bleeding after the menopause is a symptom of womb cancer, along with low pelvic pain.

It is not known what causes womb cancer, but there are a number of factors, which are known to increase the risk. This includes being overweight or obese, not having had children, late menopause or use of the drug tamoxifen, which is used to treat and prevent breast cancer.

The standard treatment for womb cancer is surgery in the form of a hysterectomy. Women in the early stages of the disease usually do not need any other treatment, although women with more advanced disease also need radiotherapy.

Report author Lucy Boyd, a Cancer Research UK epidemiologist, said: "It's encouraging to see that the incidence of womb cancer in the UK is among the lowest in Europe, but the rise in cases in older women is a concern.

"We feel it is vitally important to raise awareness of this disease and encourage women to look out for the early symptoms, which can include abnormal vaginal bleeding or discharge, bleeding after the menopause and less commonly, low pelvic pain. Survival rates would be even better if more women reported their symptoms to their doctor at an earlier stage."

Dr Lesley Walker, Director of Cancer Information at Cancer Research UK, said: "The improved survival rates are a result of the advances that have been made in successfully treating this disease. However, it is also clear that even more lives would be saved if awareness of this disease were better."

(KMcA)

Related UK National News Stories
Click here for the latest headlines.

30 September 2003
'Next big step' in breast cancer treatment launched
Cancer Research UK scientists will today embark on the next big step towards preventing breast cancer with the launch of a major new trial called IBIS II. The 10-year study will test a new drug called anastrozole and involve 10,000 healthy women who are at an increased risk of the disease.
22 April 2009
Breast Cancer Deaths At Record Low
The number of women dying from breast cancer has fallen to its lowest level since records began, new figures have shown. The data released by Cancer Research UK show that in 2007, 11,990 women in Britain died from breast cancer. In 1941 - the first year statistics were collected - 12,472 women died from the disease.
10 October 2005
Breast cancer survival rates rise
Almost two-thirds of all women newly diagnosed with breast cancer are now likely to survive for at least 20 years, a leading cancer charity has claimed.
16 November 2005
Alcohol contributing to mouth cancer rise, report claims
Alcohol is contributing to a rise in mouth cancer cases in the UK, but few people are aware that it is a risk factor for the disease, a survey has warned. Cancer Research UK said that cases of mouth cancer have risen by a quarter over the past ten years – from 3,411 in 1992 to 4,285 in 2001.
04 April 2003
Cervical cancer risk link to contraceptive pill
Women who take the contraceptive pill may increase their risk of cervical cancer, according to a major new study published in the Lancet today.